Drug Interaction Potential
1 competing product in clinical development for Drug Interaction Potential.
Pipeline by Phase
Phase 11
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Tolbutamide + Midazolam + Pexidartinib | Daiichi Sankyo | Phase 1 | Completed | 29 |